{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T01:25:47Z","timestamp":1662341147761},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1987,6,1]],"date-time":"1987-06-01T00:00:00Z","timestamp":549504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1987,6,1]],"date-time":"1987-06-01T00:00:00Z","timestamp":549504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Oncol. &amp; Tumor Pharmacother."],"published-print":{"date-parts":[[1987,6]]},"DOI":"10.1007\/bf02934941","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T18:21:13Z","timestamp":1631902873000},"page":"59-66","source":"Crossref","is-referenced-by-count":1,"title":["Iatrogenic and idiopathic acute myelogenous leukemia: A comparison of clinical features and treatment complications"],"prefix":"10.1007","volume":"4","author":[{"given":"C. K. Oladipupo","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Cuttner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Ohnuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward P.","family":"Ambinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo P. C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02934941_CR1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJM197703312961302","volume":"296","author":"J B Alavi","year":"1977","unstructured":"Alavi J B, Root R K, Djerassi I, Evans A Eet al: Clinical trial of granulocyte for infection in acute leukemia.New Engl J Med\n                  296, 706\u2013711 (1977).","journal-title":"New Engl J Med"},{"key":"BF02934941_CR2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJM197211302872204","volume":"287","author":"J C Arseneau","year":"1972","unstructured":"Arseneau J C, Sponso R W, Levin D L, Schnipper L E, Bonner H, Young R C, Canellos G P, Johnson R E, De Vita V T: Non-lymphomatous malignant tumours complicating Hodgkin\u2019s disease. Possible association with intensive therapy.New Engl J Med\n                  287, 1119\u20131122 (1972).","journal-title":"New Engl J Med"},{"key":"BF02934941_CR3","first-page":"414","volume":"20","author":"H W Bruckner","year":"1979","unstructured":"Bruckner H W, Cohen C J, Wallach R C, Kabakow B, Deppe G, Greenspan E M, Gusberg S B, Holland J F: Prospective controlled randomized trial comparing combination chemotherapy of advanced ovarian cancer with adriamycin,cis-platinum \u00b1 cyclophosphamide and Hexamethylmelamine.Proc Am Ass Cancer Res\/Am Soc Clin Oncol\n                  20, 414 (1979).","journal-title":"Proc Am Ass Cancer Res\/Am Soc Clin Oncol"},{"key":"BF02934941_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/jcp.30.11.997","volume":"30","author":"J W Cairns","year":"1977","unstructured":"Cairns J W, Healy M J R, Stafford D M, Vitok P, Waters D A W: Evaluation of the Hemalog D differential leucocyte counter.J Clin Path\n                  30, 997\u20131004 (1977).","journal-title":"J Clin Path"},{"issue":"Suppl. 2","key":"BF02934941_CR5","first-page":"979","volume":"42","author":"V T De Vita","year":"1978","unstructured":"De Vita V T, Lewis B J, Rosenzweig M, Muggia F: The chemotherapy of Hodgkin\u2019s disease. Past experiences and future directions.Cancer\n                  42, Suppl. 2, 979\u2013990 (1978).","journal-title":"Cancer"},{"key":"BF02934941_CR6","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJM198212023072302","volume":"307","author":"M H Greene","year":"1982","unstructured":"Greene M H, Boice J D, Greer B E, Blessing J A, Dembo A J: Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer. A study of five randomized studies.New Engl J Med\n                  307, 1416\u20131421 (1982).","journal-title":"New Engl J Med"},{"key":"BF02934941_CR7","first-page":"216","volume":"78","author":"T Han","year":"1978","unstructured":"Han T, Minowada J: Impairment of cell-mediated immunity of untreated Hodgkin\u2019s disease: evaluation by skin test, lymphocyte stimulation tests, and T and B lymphocyte counts.NY State J Med\n                  78, 216\u2013221 (1978).","journal-title":"NY State J Med"},{"key":"BF02934941_CR8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM197703312961301","volume":"296","author":"R H Herzig","year":"1977","unstructured":"Herzig R H, Herzig G P, Graw R C (Jr), Bull M I, Ray K K: Successful granulocyte transfusion therapy for gramnegative septicemia. A prospective randomized controlled study.New Engl J Med\n                  296, 701\u2013705 (1977).","journal-title":"New Engl J Med"},{"key":"BF02934941_CR9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM197504102921501","volume":"292","author":"D D Higby","year":"1975","unstructured":"Higby D D, Yates J W, Henderson E S, Holland J F: Filtration leukapheresis for granulocyte transfusion therapy. Clinical and Laboratory Studies.New Engl J Med\n                  292, 761\u2013766 (1975).","journal-title":"New Engl J Med"},{"key":"BF02934941_CR10","first-page":"3","volume":"6","author":"E M Jacobs","year":"1979","unstructured":"Jacobs E M, Muggia F M, Rosenzweig M: Chemotherapy of testicular cancer: from palliation to curative adjuvant chemotherapy.Semin Oncol\n                  6, 3\u201313 (1979).","journal-title":"Semin Oncol"},{"key":"BF02934941_CR11","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/1097-0142(197803)41:3<1040::AID-CNCR2820410336>3.0.CO;2-N","volume":"41","author":"E T Kohorn","year":"1978","unstructured":"Kohorn E T, Mitchell M S, Dwyer J M, Knowlton A H, Klein-Angerer S: Effect of radiation on cell-mediated cytotoxicity and lymphocyte populations in patients with ovarian carcinoma.Cancer\n                  41, 1040\u20131048 (1978).","journal-title":"Cancer"},{"key":"BF02934941_CR12","first-page":"369","volume":"2","author":"H D Preisler","year":"1976","unstructured":"Preisler H D, Bjonsson E: Protected environment units in the treatment of acute leukemia.Semin Oncol\n                  2, 369\u2013377 (1976).","journal-title":"Semin Oncol"},{"key":"BF02934941_CR13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajh.2830030301","volume":"3","author":"H D Preisler","year":"1977","unstructured":"Preisler H D, Lyman G H: Acute myelogenous leukemia subsequent to therapy for a different neoplasm: clinical features and response to therapy.Am J Hemat\n                  3, 209\u2013218 (1977).","journal-title":"Am J Hemat"},{"key":"BF02934941_CR14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM198301063080105","volume":"308","author":"H H Preisler","year":"1983","unstructured":"Preisler H H, Early A P, Raza A, Vlatides G, Marinello M J, Stein A M, Browman G: Therapy of secondary acute nonlymphocytic leukemia with cytarabine.New Engl J Med\n                  308, 21\u201323, (1983).","journal-title":"New Engl J Med"},{"key":"BF02934941_CR15","first-page":"394","volume":"20","author":"R F Rajak","year":"1979","unstructured":"Rajak R F, Nissen H I, Statzman L, Hoogstraten B, Cooper M R, Glowienka L P, Glidewell O, Glickman A, for Cancer and Leukemia Group B: Acute myeloid leukemia (AML) occurring during complete remission (CR) in Hodgkin\u2019s disease.Proc Am Ass Clin Res\/Am Soc Clin Oncol\n                  20, 394 (1979).","journal-title":"Proc Am Ass Clin Res\/Am Soc Clin Oncol"},{"key":"BF02934941_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1056\/NEJM197707282970402","volume":"297","author":"R R Reimer","year":"1977","unstructured":"Reimer R R, Hoover R, Fraumeni J F, Young R C: Acute leukemia after alkylating-agent therapy of ovarian cancer.New Engl J Med\n                  297, 177\u2013181 (1977).","journal-title":"New Engl J Med"},{"issue":"3","key":"BF02934941_CR17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00005792-197805000-00005","volume":"57","author":"V Rodriquez","year":"1978","unstructured":"Rodriquez V, Bodey G P, Freireich E J, McCredie F B, Gutterman J U, Keating M J, Smith T L, Gohan E A: Randomized trial of protected environment\u2014 prophylactic antibiotics in 145 adults with acute leukemia.Medicine (Baltimore)57(3), 253\u2013266 (1978).","journal-title":"Medicine (Baltimore)"},{"key":"BF02934941_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0002-9343(75)90600-2","volume":"58","author":"F Rosner","year":"1975","unstructured":"Rosner F, Gruenwald H for Acute Leukemia Group B: Hodgkin\u2019s disease and acute leukemia.Am J Med\n                  58, 339\u2013353 (1975).","journal-title":"Am J Med"},{"key":"BF02934941_CR19","doi-asserted-by":"crossref","unstructured":"Rowley J D, Golomb H M, Hardiman J: Acute leukemia after treatment of lymphoma (Letter).New Engl J Med 1013 (1977).","DOI":"10.1056\/NEJM197711032971815"},{"issue":"Suppl. 2","key":"BF02934941_CR20","first-page":"839","volume":"42","author":"J V Simone","year":"1979","unstructured":"Simone J V, Aur R J A, Hustu H O, Verzosa M S, Pinkel D: Three to ten years after cessation of therapy in children with leukemia.Cancer\n                  42 (Suppl. 2), 839\u2013844 (1979).","journal-title":"Cancer"},{"key":"BF02934941_CR21","first-page":"360","volume":"20","author":"P Valagussa","year":"1979","unstructured":"Valagussa P, Kenda R, Bellani P F, Pranchi F, Banfi A, Rilko F, Bonadonna G: Incidence of second malignancies in Hodgkin\u2019s disease (HD) after various forms of treatment.Am Soc Clin Oncol\n                  20, 360 (1979).","journal-title":"Am Soc Clin Oncol"},{"key":"BF02934941_CR22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V42.4.571.571","volume":"42","author":"P L Weiden","year":"1973","unstructured":"Weiden P L, Lerner K G, Geddes A, Heywood J D, Fefer A, Thomas E D: Pancytopenia and leukemia in Hodgkin\u2019s disease: report of three cases.Blood\n                  42, 571\u2013577 (1973).","journal-title":"Blood"},{"key":"BF02934941_CR23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM197708042970504","volume":"297","author":"S A Weitzman","year":"1977","unstructured":"Weitzman S A, Aisenberg A C, Siber G R, Smith D H: Impaired humoral immunity in treated Hodgkin\u2019s disease.New Engl J Med\n                  297, 245\u2013248 (1977).","journal-title":"New Engl J Med"},{"key":"BF02934941_CR24","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/1097-0142(197312)32:6<1490::AID-CNCR2820320628>3.0.CO;2-6","volume":"32","author":"J W Yates","year":"1973","unstructured":"Yates J W, Holland J F: A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients.Cancer\n                  32, 1490\u20131498 (1973).","journal-title":"Cancer"},{"key":"BF02934941_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0002-9343(72)90008-3","volume":"52","author":"R C Young","year":"1972","unstructured":"Young R C, Cordor N P, Haynes H A: Delayed hypersensitivity in Hodgkin\u2019s disease. A study of 103 untreated patients.Am J Med\n                  52, 63\u201372 (1972).","journal-title":"Am J Med"},{"key":"BF02934941_CR26","first-page":"280","volume":"298","author":"M N Zarrabi","year":"1978","unstructured":"Zarrabi M N, Rosner F, Bonnett J M: Acute leukemia and non-Hodgkin\u2019s lymphomas.New Engl J Med\n                  298, 280 (1978).","journal-title":"New Engl J Med"},{"key":"BF02934941_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ajh.2830070408","volume":"7","author":"M H Zarrabi","year":"1979","unstructured":"Zarrabi M H, Rosner F: Acute myeloblastic leukemia following treatment for non-hematopoietic cancers: report of 19 cases and review of the literature.Am J Hemat\n                  7, 357\u2013367 (1979).","journal-title":"Am J Hemat"},{"key":"BF02934941_CR28","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0140-6736(79)92627-8","volume":"ii","author":"J L Ziegler","year":"1979","unstructured":"Ziegler J L, Magrath I T, Olweny C L M: Cure of Burkitt\u2019s lymphoma.Lancet\n                  ii, 936\u2013938 (1979).","journal-title":"Lancet"}],"container-title":["Medical Oncology and Tumor Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02934941.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02934941\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02934941.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T19:07:23Z","timestamp":1631905643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02934941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1987,6]]}},"alternative-id":["BF02934941"],"URL":"https:\/\/doi.org\/10.1007\/bf02934941","relation":{},"ISSN":["0736-0118"],"issn-type":[{"value":"0736-0118","type":"print"}],"subject":[],"published":{"date-parts":[[1987,6]]}}}